The CHA(2)DS(2)-VASc score for predicting atrial fibrillation in patients presenting with ST elevation myocardial infarction: prospective observational study


Aksoy F., Bas H. A. , Bagci A., Oskay T.

SAO PAULO MEDICAL JOURNAL, vol.137, no.3, pp.248-254, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 137 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.1590/1516-3180.2018.0431140319
  • Journal Name: SAO PAULO MEDICAL JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.248-254
  • Keywords: Risk factors, Atrial fibrillation, Myocardial infarction, 3RD UNIVERSAL DEFINITION, ACUTE CORONARY SYNDROMES, 2016 ESC GUIDELINES, PROGNOSTIC-SIGNIFICANCE, SEGMENT ELEVATION, MANAGEMENT, COLLABORATION, INFLAMMATION, ASSOCIATION, MORTALITY
  • Süleyman Demirel University Affiliated: Yes

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common form of supraventricular arrhythmia following ST-elevation myocardial infarction (STEMI). The CHA(2)DS(2)-VASc and CHADS(2) scores are used to estimate thromboembolic risk in cases of AF. Their usefulness in predicting the development of AF in patients presenting STEMI is unknown.